Regulatory Filings • Sep 7, 2022
Regulatory Filings
Open in ViewerOpens in native device viewer
RaySearch Laboratories AB (publ) announces that Sunnybrook Health Sciences Centre – Odette Cancer Centre in Toronto, Canada, has placed an order for RayStation®*treatment planning system.
Sunnybrook Health Sciences Centre, one of Canada's largest hospitals, offers a highly specialized comprehensive cancer program and treats more than 7,000 cancer patients per year. The center is equipped with 13 linear accelerators. This is the first sale made in Ontario since a Master Purchase Agreement was signed with Ontario Health in the first quarter of 2022.
The agreement includes a complete configuration of RayStation to fully replace the hospital's existing treatment planning systems. The total order value is approximately CAD 6,2 million (approximately SEK 51,1 million), where of which at least CAD 3,5 million (SEK 28,8 million) is expected to be recognized as revenue in quarter 3 2022. Post-warranty support services are not included and will amount to an additional CAD 1,88 million (approximately SEK 15,4 million) over the next eight years. A 36-month warranty is included in the order.
Johan Löf, founder and CEO, RaySearch, says: "Canada has one of the world's most advanced cancer care programs within its universal healthcare system. RaySearch has many strong relationships with Canadian centers, both clinical and academic, and we are proud to see that also Sunnybrook has put their trust in us and our innovative software. We look forward to working with this large and well-known center to further advance cancer treatment."
This information is information that RaySearch Laboratories AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, at 08.00 CET on September 7, 2022.
Sunnybrook has evolved from its origin as Canada's largest veterans' hospital, founded in 1946, into an internationally recognized health sciences centre, fully affiliated with the University of Toronto as a teaching hospital.With 1.3 million patient visits each year, Sunnybrook has established itself across three campuses and is home to Canada's largest trauma centre. Sunnybrook's groundbreaking research changes the way patients are treated around the world. The over 200 scientists and clinician-scientists conduct more than \$100 million of breakthrough research each year. More information is available at sunnybrook.ca.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®*treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch software is used by over 800 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
RayStation®*is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.
* Subject to regulatory clearance in some markets.
For more information, please contact: Johan Löf, founder and CEO, RaySearch Laboratories AB (publ) Telephone: +46 (0) 8 510 530 00 [email protected]
Björn Hårdemark, interim CFO, RaySearch Laboratories AB (publ) Telephone: +46 (0) 709 564 217 [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.